Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eplerenone for LVH Regression in Hypertensive Patients with CLCNKA Polymorphism
NCT01275352Phase 4Withdrawn
- Sponsor
- Washington University School of Medicine
- Start
- Dec 2011
- Primary completion
- Dec 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of eplerenone in hypertension (HTN), sponsored by Washington University School of Medicine. Planned start Dec 2011; status: withdrawn.
02
Drugs
eplerenone
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT01275352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01275352.